AbbVie Inc. (ABBV) financials

AbbVie Inc. (ABBV) revenue, EBIT and EBITDA, earnings per share, free cash flow, margins, debt and shareholders equity — annual and quarterly history, charted from SEC filings. No account needed.

In fiscal 2025, AbbVie Inc. reported revenue of $61.16B, up 8.6% year over year, net income of $4.23B, diluted EPS of $2.36 and free cash flow of $17.82B.

Revenue (fiscal 2025)

$61.16B

Revenue growth (fiscal 2025)

8.6%

Net income (fiscal 2025)

$4.23B

Diluted EPS (fiscal 2025)

$2.36

Free cash flow (fiscal 2025)

$17.82B

AbbVie Inc. files with the U.S. Securities and Exchange Commission under CIK 0001551152, classified as Pharmaceutical Preparations.

Explore annual and quarterly revenue, earnings, cash flow, margins, debt and equity from SEC filings.